Literature DB >> 14532168

Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue.

Rikke Krogh-Madsen1, Peter Plomgaard, Pernille Keller, Charlotte Keller, Bente Klarlund Pedersen.   

Abstract

High circulating levels of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) are found in patients with hyperinsulinemia. Insulin stimulates release of IL-6 from adipocyte cultures, and it stimulates IL-6 gene expression in insulin-resistant, but not control, rat skeletal muscle. In addition, TNF-alpha may be involved in the pathogenesis of insulin resistance. Therefore, we studied the effect of insulin on IL-6 and TNF-alpha gene expression in human skeletal muscle and adipose tissue. Nine healthy young volunteers participated in the study. They underwent a 6-h hyperinsulinemic euglycemic clamp at a fixed insulin infusion rate, with blood glucose clamped at fasting level. Blood samples drawn at 0, 1, 2, 3, 4, 5, and 6 h were analyzed for IL-6 and TNF-alpha. Muscle and fat biopsies, obtained at 0, 2, 4, and 6 h, were analyzed for IL-6 and TNF-alpha mRNA with real-time PCR. IL-6 mRNA increased 11-, 3-, and 5-fold at 2, 4, and 6 h, respectively, in adipose tissue (ANOVA P = 0.027), whereas there was no significant effect of insulin on skeletal muscles. Plasma IL-6 increased during insulin stimulation. TNF-alpha mRNA increased 2.4-, 1.4-, and 2.2-fold in adipose tissue (ANOVA P = 0.001) and decreased 0.74-, 0.64-, and 0.68-fold in muscle tissue (ANOVA P = 0.04). Plasma levels of TNF-alpha were constant. In conclusion, the finding that insulin stimulates IL-6 and TNF-alpha gene expression in adipose tissue only and inhibits the TNF-alpha production in skeletal muscles suggests a differential regulation of muscle- and adipose tissue-derived IL-6 and TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532168     DOI: 10.1152/ajpendo.00274.2003

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  34 in total

Review 1.  Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.

Authors:  Efrat Kravitz; James Schmeidler; Michal Schnaider Beeri
Journal:  Endocrinol Metab Clin North Am       Date:  2013-09       Impact factor: 4.741

2.  Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects.

Authors:  J Westerbacka; A Cornér; K Kannisto; M Kolak; J Makkonen; E Korsheninnikova; T Nyman; A Hamsten; R M Fisher; H Yki-Järvinen
Journal:  Diabetologia       Date:  2005-12-16       Impact factor: 10.122

Review 3.  Insulin action and resistance in obesity and type 2 diabetes.

Authors:  Michael P Czech
Journal:  Nat Med       Date:  2017-07-11       Impact factor: 53.440

4.  A short-term diet and exercise intervention ameliorates inflammation and markers of metabolic health in overweight/obese children.

Authors:  Ali Izadpanah; R James Barnard; Anna Jane E Almeda; Gayle C Baldwin; Sydney A Bridges; Erin R Shellman; Charles F Burant; Christian K Roberts
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-19       Impact factor: 4.310

5.  Effects of supplementation with rice husk powder and rice bran on inflammatory factors in overweight and obese adults following an energy-restricted diet: a randomized controlled trial.

Authors:  Fahimeh Edrisi; Mousa Salehi; Afsane Ahmadi; Mohamad Fararoei; Fatemeh Rusta; Salma Mahmoodianfard
Journal:  Eur J Nutr       Date:  2017-10-23       Impact factor: 5.614

Review 6.  Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulation.

Authors:  Fabiana B Benatti; Bente K Pedersen
Journal:  Nat Rev Rheumatol       Date:  2014-11-25       Impact factor: 20.543

7.  Psychoneuroimmune implications of type 2 diabetes: redux.

Authors:  Jason C O'Connor; Daniel R Johnson; Gregory G Freund
Journal:  Immunol Allergy Clin North Am       Date:  2009-05       Impact factor: 3.479

Review 8.  The major inflammatory mediator interleukin-6 and obesity.

Authors:  Katalin Eder; Noemi Baffy; Andras Falus; Andras K Fulop
Journal:  Inflamm Res       Date:  2009-06-19       Impact factor: 4.575

9.  Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness.

Authors:  A L Carey; C R Bruce; M Sacchetti; M J Anderson; D B Olsen; B Saltin; J A Hawley; M A Febbraio
Journal:  Diabetologia       Date:  2004-05-28       Impact factor: 10.122

Review 10.  Hyperinsulinemia in Obesity, Inflammation, and Cancer.

Authors:  Anni M Y Zhang; Elizabeth A Wellberg; Janel L Kopp; James D Johnson
Journal:  Diabetes Metab J       Date:  2021-03-29       Impact factor: 5.893

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.